Permissive Cardiotoxicity: An Evolving Paradigm

By afschroeder • October 11, 2026

Madnick DL, Hutchins E, Stein-Merlob AF, Yang EH. Permissive Cardiotoxicity: An Evolving Paradigm. J Am Heart Assoc. 2026 Oct 10:e051633. doi: 10.1161/JAHA.126.051633. Epub ahead of print. PMID: 42858010.

Tags: cardio‐oncology, Cardiology/Epi, cardioprotective therapies, chemotherapy‐induced cardiac injury, Fellow, permissive cardiotoxicity, Publications

Sex Differences in the Prevalence, Medical Therapy, and Outcomes in Heart Failure With Improved Ejection Fraction

Liang Y, Shah L, Parikh RV, Go AS, Lee KK, Ambrosy AP, Tan TC, Pabon MA, Vardeny O, Naderi S, Svetlichnaya J, Solomon SD, Inciardi[...]

Factors Associated With Mineralocorticoid Receptor Antagonist Initiation in Newly Diagnosed Heart Failure

Fonarow GC, Lam CSP, Morris AA, Fung YM, Zheng Z, Gomez S, Holl K, Lavagnino MA, Katta A, Knapp R. Factors Associated With Mineralocorticoid Receptor[...]

Rapid progression of coronary atherosclerosis across glycemic status: a serial coronary computed tomography angiography study from the PARADIGM registry

Won KB, Lee BK, Hadamitzky M, Kim YJ, Sung JM, Conte E, Pontone G, Andreini D, Budoff MJ, Gottlieb I, Chun EJ, Cademartiri F, Maffei[...]